Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (2S) 2 (2 amino 5 chlorophenyl) 4 cyclopropyl 1,1,1 trifluoromethyl 3 butyn 2 ol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111548317A reveals a novel Efavirenz synthesis using Zinc Chloride, offering significant cost reduction and improved yield for pharmaceutical intermediate manufacturing.